NCT03917628View on ClinicalTrials.gov

Pharmacokinetics and Safety in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

May 29, 2019

Primary Completion Date

November 4, 2019

Study Completion Date

November 4, 2019

Conditions
Healthy
Interventions
DRUG

SCT630

SCT630 single s.c. injection

DRUG

adalimumab-EU source

adalimumab-EU source single s.c. injection

Trial Locations (1)

100038

Beijing SHIJITAN Hospital, Beijing

All Listed Sponsors
lead

Sinocelltech Ltd.

INDUSTRY

NCT03917628 - Pharmacokinetics and Safety in Healthy Volunteers | Biotech Hunter | Biotech Hunter